If you have already registered, please check your email for the webinar link.

Event Overview

The solid tumor microenvironment is immunosuppressive and poses a significant obstacle to achieving clinical success with various immunotherapies. Most notably, immune checkpoint pathways, including PD-1, PD-L1, and CTLA-4, allow tumors to evade the body’s usual immune reaction, leading to disease progression. Checkpoint blockade via monoclonal antibodies results in augmented T-cell activation and proliferation to enhance the anti-tumor immune response and has revolutionized the field, but not all patients are candidates and severe adverse effects persist. Therefore, the development of other approaches, such as antibody-drug conjugates, vaccines, and adoptive cell-based therapies, has surged. Recent advances in immunotherapy have certainly produced enhanced treatment options for solid tumors, but obstacles to their mainstream use remain. To explore novel strategies in immuno-oncology for solid tumors, The Scientist is bringing together a panel of experts to share their research and insights into what it may take to overcome the barriers in the tumor microenvironment.

Topics to be Covered

  • Immunotherapy in Lung Cancer
  • Adoptive Immunotherapy: Overcoming Barriers Against Solid Tumors with Potent T cells
Tuesday, June 18, 2019
2:30 - 4:00 PM Eastern Time


Dy 100x100.png
Grace Dy, MD
Chief, Thoracic Oncology
Associate Professor of Oncology
Department of Medicine
Roswell Park Comprehensive Cancer Center

Paulos 100x100.png
Chrystal Paulos, PhD
Associate Professor of Microbiology and Immunology
Co-Leader of the Cancer Immunology Program at the Hollings Cancer Center
Endowed Peng Chair of Melanoma in Department of Dermatology and Dermatological Surgery
Medical University of South Carolina, College of Medicine

Horizon Logobox.png

Register Now

Immuno-Oncology for Solid Tumors: Overcoming Barriers in the Tumor Microenvironment

You must have Javascript and Cookies enabled to access this webcast.

Information you provide will be held in confidence and will be shared with the sponsoring vendor(s) of this webinar. Bio-Techne may use the information to contact you about your account and to let you know about related programs and products; you may opt-out at any time. This allows The Scientist to keep these webinars free of charge for our readers.